Difference between revisions of "P-glycoprotein modifying drugs"
Jump to navigation
Jump to search
(Created page with "=P-glycoprotein substrates= *Colchicine *Cyclosporine *Digoxin *Fexofenadine *Indinavir *Morphine *Sirolimus (Rapamune) =P-glycoprotein inhibi...") |
Warner-admin (talk | contribs) m (Text replacement - "[[:Category:Cyclosporines" to "[[Cyclosporine") |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
=P-glycoprotein substrates= | =P-glycoprotein substrates= | ||
*Colchicine | *Colchicine | ||
| − | *[[ | + | *[[Cyclosporine|Cyclosporine]] |
*Digoxin | *Digoxin | ||
*Fexofenadine | *Fexofenadine | ||
| Line 24: | Line 24: | ||
[[Category:General reference pages]] | [[Category:General reference pages]] | ||
| + | [[Category:Clinical pharmacology]] | ||
Latest revision as of 21:42, 26 August 2021
P-glycoprotein substrates
- Colchicine
- Cyclosporine
- Digoxin
- Fexofenadine
- Indinavir
- Morphine
- Sirolimus (Rapamune)
P-glycoprotein inhibitors
- Amiodarone
- Clarithromycin (Biaxin)
- Erythromycin
- Ketoconazole (Nizoral)
- Quinidine
- Saquinivir
- Verapimil
P-glycoprotein inducers
- Carbamazepine
- Rifampin
- St. John's wort
- Tipranavir